Cite
In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication.
MLA
Marsden, Matthew D., et al. “In Vivo Activation of Latent HIV with a Synthetic Bryostatin Analog Effects Both Latent Cell ‘Kick’ and ‘Kill’ in Strategy for Virus Eradication.” PLoS Pathogens, vol. 13, no. 9, Sept. 2017, pp. 1–19. EBSCOhost, https://doi.org/10.1371/journal.ppat.1006575.
APA
Marsden, M. D., Loy, B. A., Wu, X., Ramirez, C. M., Schrier, A. J., Murray, D., Shimizu, A., Ryckbosch, S. M., Near, K. E., Chun, T.-W., Wender, P. A., & Zack, J. A. (2017). In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell “kick” and “kill” in strategy for virus eradication. PLoS Pathogens, 13(9), 1–19. https://doi.org/10.1371/journal.ppat.1006575
Chicago
Marsden, Matthew D., Brian A. Loy, Xiaomeng Wu, Christina M. Ramirez, Adam J. Schrier, Danielle Murray, Akira Shimizu, et al. 2017. “In Vivo Activation of Latent HIV with a Synthetic Bryostatin Analog Effects Both Latent Cell ‘Kick’ and ‘Kill’ in Strategy for Virus Eradication.” PLoS Pathogens 13 (9): 1–19. doi:10.1371/journal.ppat.1006575.